Amgen, after the acquisition of Nuevolution and its world-class DNA-encoded library (DEL) platform, Amgen has a team of expert’s adept at making and screening billions to trillions of compounds to find promising leads. The huge increase in screening power will fuel Amgen’s search for bispecific small molecules that use the body’s cellular machinery to tackle
AstraZeneca and Novoheart are collaborating on developing a functioning miniature human heart model of heart failure, a first of its kind. The ‘heart-in-a-jar’, Novoheart’s proprietary 3D human ventricular cardiac organoid chamber (hvCOC) technology, will be made from human stem cells and will replicate the key characteristics of heart failure. This will include preserved ejection fraction
Hertfordshire Local Enterprise Partnership announced plans to invest an extra £1.2 million into Stevenage Bioscience Catalyst (SBC), in order to “help grow a world-class cell and gene therapy cluster.” The money will help reinforce the campus as a world class cell and gene therapy cluster, providing much-needed temporary accommodation for growing companies of that nature.
Oxford Drug Design (ODD) has won a UK-China antimicrobial resistance grant, in addition to also boosting its funding with investment from the Angel CoFund. Oxford Drug Design Limited has raised a combined £2.2m in funding from the Angel CoFund (ACF), o2h Ventures and other new investors. Whilst also gaining grant funding from the UK Department
A new study has suggested that whilst treating peanut allergy with regular exposure to small amounts of the food is effective it is only if a patient stays on the therapy. The King’s College London scientists conducting the looked at the underlying behaviour of patients’ cells and found it did not change. They stated it
According to scientist a rare and unfortunate sequence of events have allowed a deadly type of malaria in gorillas to “jump” species and attack humans. Hundreds of thousands of people die from malaria every year and Plasmodium falciparum, the type the researchers studied, is responsible in most cases. Experts have found that although African great apes
GSK and Lyell Immunopharma have announced a five-year collaboration to develop new technologies with the aim of improving cell therapies for cancer patients. In the announcement the companies explained that the collaboration will apply Lyell’s technologies to further strengthen GSK’s cell therapy pipeline, including GSK3377794, which targets the NY-ESO-1 antigen that is expressed across multiple
Novartis and Microsoft have announced a new collaboration with the aim to “transform medicine with artificial intelligence.” Novartis announced the “important step in reimagining medicine” by founding the Novartis AI innovation lab, choosing Microsoft as its strategic AI and data-science partner. The company says that the new lab will look to bolster Novartis AI capabilities
The University has established a new institute to obtain earlier diagnosis of cancer, cardiovascular disease, mental health and infection and help address current inequalities. Early diagnosis is critical in order to achieve the best treatment outcomes, yet diseases are much more likely to be diagnosed earlier in affluent areas compared to Scotland’s most deprived communities.
A new study from the University of Rochester Medical Center in the United States, features a needle-free flu vaccine patch to can boost the immune system like a traditional flu shot without any negative side effects. The results of the study have been noted as an important step towards technology that could replace needle-based vaccination methods. “Our patch